Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-12

Clinical Trial Update: A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular Damage

View source ↗

Summary

A pilot clinical trial examines whether Ticagrelor can protect against vascular damage caused by type 2 diabetes mellitus in patients with stable coronary disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TICAGRELOR (ticagrelor)

Snippet

Sponsor: Tianjin Medical University | Conditions: Type 2 Diabetes Mellitus;, Stable Coronary Disease | Status: UNKNOWN